Article metrics

Download PDFPDF

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019110
Jan 2020440
Feb 202040403
Mar 202030304
Apr 202022223
May 2020393912
Jun 202022222
Jul 202045453
Aug 2020242410
Sep 202031318
Oct 202038385
Nov 202021205
Dec 202021214
Jan 2021232316
Feb 202122222
Mar 202148483
Apr 202159599
May 2021575715
Jun 202152527
Jul 202164644
Aug 202145457
Sep 2021555516
Oct 2021636324
Nov 2021555418
Dec 2021545412
Jan 202250518
Feb 2022464710
Mar 202227279
Apr 202232338
May 2022383815
Jun 2022616212
Jul 202254554
Aug 2022707010
Sep 2022293111
Oct 202231329
Nov 2022242719
Dec 202220208
Jan 202318189
Feb 202353536
Mar 2023252610
Apr 2023171712
May 202324249
Jun 202317174
Jul 202315159
Aug 202310105
Sep 202316163
Oct 202311117
Nov 202326263
Dec 202335359
Jan 202418196
Feb 202438388
Mar 2024404011
Apr 2024383812
May 2024222210
Jun 2024363514
Jul 2024656612
Aug 2024444359
Sep 202437375
Oct 2024272712
Nov 202428292
Dec 202412126
Jan 2025262619
Feb 2025373716
Mar 2025444415
Apr 2025353511
May 2025353512
Jun 2025333420
Jul 2025220
Total23012313651